These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 22188854)

  • 21. Threshold for NIH stroke scale in predicting vessel occlusion and functional outcome after stroke thrombolysis.
    Cooray C; Fekete K; Mikulik R; Lees KR; Wahlgren N; Ahmed N
    Int J Stroke; 2015 Aug; 10(6):822-9. PubMed ID: 25588617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extending thrombolysis to 4·5-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data.
    Campbell BCV; Ma H; Ringleb PA; Parsons MW; Churilov L; Bendszus M; Levi CR; Hsu C; Kleinig TJ; Fatar M; Leys D; Molina C; Wijeratne T; Curtze S; Dewey HM; Barber PA; Butcher KS; De Silva DA; Bladin CF; Yassi N; Pfaff JAR; Sharma G; Bivard A; Desmond PM; Schwab S; Schellinger PD; Yan B; Mitchell PJ; Serena J; Toni D; Thijs V; Hacke W; Davis SM; Donnan GA;
    Lancet; 2019 Jul; 394(10193):139-147. PubMed ID: 31128925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reperfusion and outcomes in Penumbra vs. systemic tissue plasminogen activator clinical trials.
    Alexandrov AV; Schellinger PD; Saqqur M; Barreto A; Demchuk AM; Ribo M; Rubiera M; Sharma VK; Heliopoulos I; Alexandrov AW; Molina CA; Tsivgoulis G;
    Int J Stroke; 2011 Apr; 6(2):118-22. PubMed ID: 21371272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.
    Hacke W; Albers G; Al-Rawi Y; Bogousslavsky J; Davalos A; Eliasziw M; Fischer M; Furlan A; Kaste M; Lees KR; Soehngen M; Warach S;
    Stroke; 2005 Jan; 36(1):66-73. PubMed ID: 15569863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging-based thrombolysis trial in acute ischemic stroke-II (ITAIS-II).
    Wang Y; Liao X; Zhao X; Wang C; Liu L; Zhou Y; Wang C; Xue J; Gao P; Dong K; Ji X; Wang Y;
    Int J Stroke; 2009 Feb; 4(1):49-53; discussion 49. PubMed ID: 19236499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study.
    Ahmed N; Kellert L; Lees KR; Mikulik R; Tatlisumak T; Toni D;
    JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.
    Bluhmki E; Chamorro A; Dávalos A; Machnig T; Sauce C; Wahlgren N; Wardlaw J; Hacke W
    Lancet Neurol; 2009 Dec; 8(12):1095-102. PubMed ID: 19850525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusionLi YH; Li MH; Zhao ZG; Bai QK
    Neurol India; 2009; 57(4):426-33. PubMed ID: 19770543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
    Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships Between Imaging Assessments and Outcomes in Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke.
    Albers GW; Goyal M; Jahan R; Bonafe A; Diener HC; Levy EI; Pereira VM; Cognard C; Yavagal DR; Saver JL
    Stroke; 2015 Oct; 46(10):2786-94. PubMed ID: 26316344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombectomy in patients ineligible for iv tPA (THRILL).
    Bendszus M; Thomalla G; Knauth M; Hacke W; Bonekamp S; Fiehler J
    Int J Stroke; 2015 Aug; 10(6):950-5. PubMed ID: 26044962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant tissue plasminogen activator for minor strokes: the National Institute of Neurological Disorders and Stroke rt-PA Stroke Study experience.
    National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group
    Ann Emerg Med; 2005 Sep; 46(3):243-52. PubMed ID: 16126134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time of day, outcome, and response to thrombolytic therapy: the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Trial experience.
    Rhoney DH; Coplin WM; Lin Y; Frankel M; Lyden PD; Levine SR
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):40-8. PubMed ID: 20123226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective, randomized, placebo-controlled, double-blind trial about safety and efficacy of combined treatment with alteplase (rt-PA) and Cerebrolysin in acute ischaemic hemispheric stroke.
    Lang W; Stadler CH; Poljakovic Z; Fleet D;
    Int J Stroke; 2013 Feb; 8(2):95-104. PubMed ID: 23009193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study.
    Luo Z; Zhou Y; He Y; Yan S; Chen Z; Zhang X; Chen Y; Tong LS; Zhong W; Hu H; Zhang K; Yang J; Campbell BCV; Lou M
    Stroke Vasc Neurol; 2024 Jun; 9(3):318-323. PubMed ID: 37527920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET).
    De Silva DA; Fink JN; Christensen S; Ebinger M; Bladin C; Levi CR; Parsons M; Butcher K; Barber PA; Donnan GA; Davis SM;
    Stroke; 2009 Aug; 40(8):2872-4. PubMed ID: 19478228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial.
    IST-3 collaborative group
    Lancet Neurol; 2015 May; 14(5):485-96. PubMed ID: 25819484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statistical Analysis Plan for EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND) trial.
    Churilov L; Ma H; Campbell BC; Davis SM; Donnan GA
    Int J Stroke; 2020 Feb; 15(2):231-238. PubMed ID: 30523735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.